MLV analyst George Zavoico is out again today with a new research note on Cerus (NASDAQ:CERS), raising his price target to $10 (from $7), while maintaining a …
It’s been a rough run for Brazilian state-controlled oil giant Petrobras(NYSE:PBR). The stock has been in almost continuous decline since late 2009 and …
In a research report published today, Roth Capital analyst Chris Lewis maintained a Buy rating on Enteromedics (NASDAQ:ETRM) with a $3.00 price target, …
Roth Capital analyst Joseph Pantginis maintained a Buy rating on Synta Pharmaceuticals (NASDAQ:SNTA) with a $27 price target, as the company announced interim data from …
In a research report sent to investors today, Roth Capital analyst Krishna Shankar reiterated a Buy rating on InvenSense Inc (NYSE:INVN) with a …
In a research report sent to investors, Roth Capital analyst Joseph Pantginis reiterated a Buy rating on TG Therapeutics (NASDAQ:TGTX) with a price …
In a research report sent to investors today, Maxim Group analyst Jason Kolbert reiterated a Buy rating on OncoSec Medical (OTC:ONCS) with a …
In a research report released this morning, Cantor analyst Brian White maintained a Buy rating on Apple (NASDAQ:AAPL) with a $143 price target, …
In a research report sent to investors today, Cowen analyst Boris Peaker initiated coverage on Keryx Biopharmaceuticals (NASDAQ:KERX) with an Outperform rating and a $25 …
William Blair analyst Brian Weinstein reiterated an Outperfom rating on Sequenom (NASDAQ:SQNM), following the news that Sequenom and Illumina reached an agreement to settle all pending IP claims …
